These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19277924)

  • 1. Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome.
    Horvat D; Severson J; Uddin MN; Mitchell B; Puschett JB
    Hypertens Pregnancy; 2010 Jan; 29(1):1-9. PubMed ID: 19277924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differing effects of resibufagenin on cinobufatalin- versus marinobufagenin-induced preeclampsia in a rodent model.
    Puschett JB; Kumar B; Abbas MM
    Am J Perinatol; 2015 Jul; 32(8):803-8. PubMed ID: 25545447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resibufogenin corrects hypertension in a rat model of human preeclampsia.
    Vu H; Ianosi-Irimie M; Danchuk S; Rabon E; Nogawa T; Kamano Y; Pettit GR; Wiese T; Puschett JB
    Exp Biol Med (Maywood); 2006 Feb; 231(2):215-20. PubMed ID: 16446498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marinobufagenin, resibufogenin and preeclampsia.
    Puschett JB; Agunanne E; Uddin MN
    Biochim Biophys Acta; 2010 Dec; 1802(12):1246-53. PubMed ID: 20167272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resibufogenin administration prevents oxidative stress in a rat model of human preeclampsia.
    Uddin MN; Agunanne EE; Horvat D; Puschett JB
    Hypertens Pregnancy; 2012; 31(1):70-8. PubMed ID: 21174582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of preeclampsia in a rat model employing Digibind.
    Agunanne E; Horvat D; Uddin MN; Puschett J
    Am J Perinatol; 2010 Apr; 27(4):299-305. PubMed ID: 19823966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marinobufagenin predicts and resibufogenin prevents preeclampsia: a review of the evidence.
    Puschett JB
    Am J Perinatol; 2012 Nov; 29(10):777-85. PubMed ID: 22814872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of angiogenic factors in a rat model of pre-eclampsia.
    Agunanne EE; Uddin MN; Horvat D; Puschett JB
    Am J Nephrol; 2010; 32(4):332-9. PubMed ID: 20720407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of resibufogenin in experimental hypertension.
    Danchuk S; Sukhanov S; Horvat D; Uddin MN; Puschett JB
    Am J Nephrol; 2008; 28(1):8-13. PubMed ID: 17890853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin-induced increase in blood pressure and markers of endothelial activation during pregnancy in Sprague Dawley rats is prevented by resibufogenin, a marinobufagenin antagonist.
    Hassan MJM; Bakar NS; Aziz MA; Basah NK; Singh HJ
    Reprod Biol; 2020 Jun; 20(2):184-190. PubMed ID: 32253169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rat model of preeclampsia.
    Ianosi-Irimie M; Vu HV; Whitbred JM; Pridjian CA; Nadig JD; Williams MY; Wrenn DC; Pridjian G; Puschett JB
    Clin Exp Hypertens; 2005 Nov; 27(8):605-17. PubMed ID: 16303637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the renin-angiotensin system in a rat model of human preeclampsia.
    Uddin MN; Agunanne E; Horvat D; Puschett JB
    Am J Nephrol; 2010; 31(2):171-7. PubMed ID: 20016143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of marinobufagenin in a rat model of human preeclampsia.
    Vu HV; Ianosi-Irimie MR; Pridjian CA; Whitbred JM; Durst JM; Bagrov AY; Fedorova OV; Pridjian G; Puschett JB
    Am J Nephrol; 2005; 25(5):520-8. PubMed ID: 16179779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular effects of the bufodienolides.
    Puschett JB
    Trans Am Clin Climatol Assoc; 2008; 119():103-12; discussion 112. PubMed ID: 18596850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characteristics shared by preeclamptic patients and an animal model of the syndrome: report of a pilot study.
    Alper AB; Outland J; Finigan K; Pridjian G; Aina-Mumuney A; Puschett JB
    Am J Hypertens; 2006 Sep; 19(9):947-50. PubMed ID: 16942938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cys-peptide mediates the protective role in preeclampsia-like rat and cell models.
    Ji X; Wang X; Ling Z; Lv Y; Yu W; Jia R; Ding H
    Life Sci; 2020 Jun; 251():117625. PubMed ID: 32247003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxin Treatment in an Ang-II-Based Transgenic Preeclamptic-Rat Model.
    Haase N; Golic M; Herse F; Rugor J; Linz D; Solano ME; Müller DN; Dechend R
    PLoS One; 2016; 11(3):e0150743. PubMed ID: 26963382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction.
    Hogg BB; Tamura T; Johnston KE; Dubard MB; Goldenberg RL
    Am J Obstet Gynecol; 2000 Oct; 183(4):805-9. PubMed ID: 11035317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium sulfate effectively reduces blood pressure in an animal model of preeclampsia.
    Standley CA; Batia L; Yueh G
    J Matern Fetal Neonatal Med; 2006 Mar; 19(3):171-6. PubMed ID: 16690511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of excessive volume expansion in the pathogenesis of preeclampsia.
    Puschett JB
    Med Hypotheses; 2006; 67(5):1125-32. PubMed ID: 16814939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.